Kim, H.Y.; Min, S.K.; Moon, J.H.; Kwak, H.; Park, S.J.
Respiratory Depression Following Concomitant Infusion of Remimazolam and Remifentanil Using Targeted Effect-Site Concentrations: A Randomized Controlled Trial. Medicina 2026, 62, 940.
https://doi.org/10.3390/medicina62050940
AMA Style
Kim HY, Min SK, Moon JH, Kwak H, Park SJ.
Respiratory Depression Following Concomitant Infusion of Remimazolam and Remifentanil Using Targeted Effect-Site Concentrations: A Randomized Controlled Trial. Medicina. 2026; 62(5):940.
https://doi.org/10.3390/medicina62050940
Chicago/Turabian Style
Kim, Ha Yeon, Sang Kee Min, Jee Hwan Moon, Hyeongjin Kwak, and Soo Jung Park.
2026. "Respiratory Depression Following Concomitant Infusion of Remimazolam and Remifentanil Using Targeted Effect-Site Concentrations: A Randomized Controlled Trial" Medicina 62, no. 5: 940.
https://doi.org/10.3390/medicina62050940
APA Style
Kim, H. Y., Min, S. K., Moon, J. H., Kwak, H., & Park, S. J.
(2026). Respiratory Depression Following Concomitant Infusion of Remimazolam and Remifentanil Using Targeted Effect-Site Concentrations: A Randomized Controlled Trial. Medicina, 62(5), 940.
https://doi.org/10.3390/medicina62050940